Novo Nordisk Pharmatech AS - Company Review
Novo Nordisk Pharmatech AS - Company ReviewSummary
Novo Nordisk Pharmatech A/S (Novo Nordisk Pharmatech), formerly FeF Chemicals A/S, a subsidiary of Novo Nordisk A/S, is a supplier of quaternary ammonium compounds. The company’s products include recombinant insulin, crystalline quaternary ammonium compounds, benzalkonium chloride, cetrimide and strong cetrimide solution. Its products are used in contraception formulations, nasal formulations, oral or dental formulations, vaccine production, antiseptic agents, opthalmics, topical formulations, veterinary products, and other pharmaceutical applications. The company offers solutions in the areas of antiseptic liquids, contraception, diagnostics and analysis, nasal, ophthalmic, dental, topical, vaccines, veterinary, and others. It caters to biopharmaceutical and pharmaceutical industries. Novo Nordisk Pharmatech is headquartered in Koge, Denmark.
This comprehensive company report of Novo Nordisk Pharmatech AS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.